Connolly Courtney T, Fox Nathan S
Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Maternal Fetal Medicine Associates, PLLC, New York, NY, USA.
J Ultrasound Med. 2022 Jun;41(6):1525-1536. doi: 10.1002/jum.15836. Epub 2021 Sep 27.
To estimate the incidence of intrauterine device (IUD) malpositioning detected on three-dimensional (3D) transvaginal ultrasound within 8 weeks of placement and identify risk factors for malpositioning.
Retrospective study of women who had an IUD placed at a large obstetrics and gynecology practice from January 1, 2015, to December 31, 2020. All patients underwent two-dimensional ultrasound at the time of insertion and routine three-dimensional ultrasound within 8 weeks. Baseline characteristics and potential risk factors were compared between women with correctly positioned and malpositioned IUDs. Odds ratios were calculated by logistic regression to identify risk factors independently associated with malpositioning.
A total of 763 IUD placements were included, and 127 malpositioned IUDs were identified representing an overall rate of malpositioning of 16.6% (95% confidence interval [CI] 14.0-19.3) with 8.8% (95% CI 6.8-10.8) requiring removal. Patients with malpositioned IUD had higher rates of morbid obesity (13.4% versus 3.8%, adjusted odds ratio [aOR] 2.46, 95% CI 1.10-5.50), prior uterine window or rupture (9.0% versus 2.2%, aOR 2.78, 95% CI 1.06-7.30), copper IUD placement (64.2% versus 47.4%, aOR 1.99, 95% CI 1.31-3.03), and symptoms such as bleeding or pain at follow-up (35.8% versus 20.1%, aOR 2.58, 95% CI 1.67-3.98). Parity, breastfeeding, difficult insertion, and uterine size and positioning were not significant.
The incidence of malpositioned IUD within 8 weeks of placement on 3D ultrasound is 16.6%, with 8.8% requiring removal. Significant risk factors for malpositioning include morbid obesity, prior uterine window or rupture, and copper IUD placement. These findings support the importance of routine follow-up 3D ultrasound after seemingly successful IUD placement.
评估放置宫内节育器(IUD)后8周内经三维(3D)经阴道超声检测到的IUD位置异常的发生率,并确定位置异常的危险因素。
对2015年1月1日至2020年12月31日在一家大型妇产科诊所放置IUD的女性进行回顾性研究。所有患者在放置时接受二维超声检查,并在8周内进行常规三维超声检查。比较IUD位置正确和位置异常的女性的基线特征和潜在危险因素。通过逻辑回归计算比值比,以确定与位置异常独立相关的危险因素。
共纳入763例IUD放置病例,其中127例IUD位置异常,总体位置异常率为16.6%(95%置信区间[CI]14.0 - 19.3),8.8%(95%CI 6.8 - 10.8)需要取出。IUD位置异常的患者病态肥胖率较高(13.4%对3.8%,调整后比值比[aOR]2.46,95%CI 1.10 - 5.50)、既往有子宫开窗或破裂史(9.0%对2.2%,aOR 2.78,95%CI 1.06 - 7.30)、放置铜IUD(64.2%对47.4%,aOR 1.99,95%CI 1.31 - 3.03)以及随访时有出血或疼痛等症状(35.8%对20.1%,aOR 2.58,95%CI 1.67 - 3.98)。产次、母乳喂养、放置困难以及子宫大小和位置无显著差异。
放置IUD后8周内3D超声检测到的IUD位置异常发生率为16.6%,8.8%需要取出。位置异常的显著危险因素包括病态肥胖、既往子宫开窗或破裂以及放置铜IUD。这些发现支持了在看似成功放置IUD后进行常规随访3D超声检查的重要性。